Article Details
Retrieved on: 2022-12-16 13:33:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
As previously reported, on June 13, 2022 , Landos Biopharma, Inc. (the "Company") received a notice from The Nasdaq Stock Market ("Nasdaq") that the ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here